ArticleMolecular therapy oncolytics2022

Redirecting anti-Vaccinia virus T cell immunity for cancer treatment by AAV-mediated delivery of the VV B8R gene.

Dujuan Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.